NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 82 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2013. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $18,000 | -25.0% | 12,568 | 0.0% | 0.00% | -50.0% |
| Q1 2014 | $24,000 | -7.7% | 12,568 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $26,000 | -21.2% | 12,568 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $33,000 | -83.5% | 12,568 | -83.2% | 0.00% | -87.5% |
| Q2 2013 | $200,000 | – | 75,013 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |